TABLE 3.
Per Protocol Analysis
| Cohort 1 Baseline Intervention | Cohort 2 Baseline +Patient Call | Cohort 3 Baseline +Provider Call | P Value Cohort 3 vs. Cohort 1 | |
|---|---|---|---|---|
| Per protocol population, n | 1,833 | 498 | 1,369 | — |
| Underwent BMD test 120 days after intervention, n (%) | 112 (6.1) | 36 (7.2) | 126 (9.2) | 0.001 |
| Initiated osteoporosis medication 120 days after intervention, n (%) | 107 (5.8) | 26 (5.2) | 113 (8.3) | <0.008 |
| Either outcome 120 days after intervention, n (%) | 189 (10.3) | 55 (11.0) | 208 (15.2) | <0.001 |
| Underwent BMD test 180 days after FID, n (%) | 171 (9.3) | 41 (8.2) | 156 (11.4) | 0.148 |
| Initiated osteoporosis medication 180 days after FID, n (%) | 115 (6.3) | 25 (5.0) | 102 (7.5) | 0.059 |
| Either outcome 180 days after FID, n (%) | 245 (13.4) | 58 (11.6) | 226 (16.5) | 0.012 |
BMD = bone mineral density; FID = fracture index date.